KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ACM Research (ACMR) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for ACM Research (ACMR) over the last 10 years, with Q3 2025 value amounting to $1.1 billion.

  • ACM Research's Cash & Equivalents rose 21754.06% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 21754.06%. This contributed to the annual value of $407.4 million for FY2024, which is 12376.02% up from last year.
  • Latest data reveals that ACM Research reported Cash & Equivalents of $1.1 billion as of Q3 2025, which was up 21754.06% from $442.1 million recorded in Q2 2025.
  • ACM Research's Cash & Equivalents' 5-year high stood at $1.1 billion during Q3 2025, with a 5-year trough of $64.5 million in Q3 2021.
  • In the last 5 years, ACM Research's Cash & Equivalents had a median value of $324.0 million in 2024 and averaged $326.6 million.
  • As far as peak fluctuations go, ACM Research's Cash & Equivalents surged by 68386.42% in 2021, and later plummeted by 5592.36% in 2022.
  • Quarter analysis of 5 years shows ACM Research's Cash & Equivalents stood at $562.5 million in 2021, then crashed by 55.92% to $248.0 million in 2022, then dropped by 26.56% to $182.1 million in 2023, then surged by 123.76% to $407.4 million in 2024, then skyrocketed by 159.89% to $1.1 billion in 2025.
  • Its Cash & Equivalents stands at $1.1 billion for Q3 2025, versus $442.1 million for Q2 2025 and $457.2 million for Q1 2025.